Relmada Therapeutics Inc. (RLMD): NEWS -- Relmada Therapeutics to Present...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Relmada Therapeutics Inc. (RLMD)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	94
Posts	11371
Boards Moderated	0
Alias Born	11/02/2003

Re: None

Tuesday, 06/09/2020 9:34:54 AM

Tuesday, June 09, 2020 9:34:54 AM

NEWS -- Relmada Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

NEW YORK, June 9, 2020 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Sergio Traversa, Chief Executive Officer of Relmada, will participate in a fireside chat at the Goldman Sachs 41st Annual Global Healthcare Conference, being held June 9-11, 2020.

Fireside Chat Details:

Date: Thursday, June 11, 2020
Time: 3:00 PM EDT
Webcast: A live webcast of the fireside chat will be available by visiting the "Investors" section of the company's website: http://www.relmada.com. A replay of the webcast will be available for 90 days following the conclusion of the live presentation broadcast.

About Relmada Therapeutics, Inc.

Relmada Therapeutics is a clinical-stage, publicly traded biotechnology company developing novel medicines to address areas of high unmet medical need in the treatment of central nervous system (CNS) diseases. Relmada's lead program, REL-1017 (dextromethadone) is an N-methyl-D-aspartate (NMDA) receptor antagonist in development for the treatment of depression. NMDA receptor antagonists may have utility in the treatment of a range of psychiatric and neurological disorders associated with a variety of cognitive, neurological and behavioral symptoms.

Investor Contact:
Tim McCarthy
LifeSci Advisors
212-915-2564
mailto://tim@lifesciadvisors.com

For Media Inquiries:
FischTank PR
mailto://relmada@fischtankpr.com

View original content to download multimedia: http://www.prnewswire.com/news-releases/relmada-therapeutics-to-present-at-the-goldman-sachs-41st-annual-global-healthcare-conference-301072754.html

SOURCE Relmada Therapeutics, Inc.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent RLMD News

Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2025 10:29:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/09/2024 12:49:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2024 12:30:15 PM
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 02:41:31 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:05:51 PM
Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm • PR Newswire (US) • 09/17/2024 01:36:00 AM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/13/2024 04:15:08 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 09:47:15 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 09:46:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 09:46:26 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/30/2024 08:23:34 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:05:43 PM
Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm • PR Newswire (US) • 07/25/2024 06:47:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 01:25:08 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 01:24:53 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 01:24:40 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 01:24:26 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 01:24:12 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 01:23:59 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:06:11 PM
US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat • IH Market News • 03/19/2024 11:27:29 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 10:55:59 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 11:29:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 11:28:58 PM

More RLMD News

InvestorsHub NewsWire

FEATURED Zefiro Methane Corp. Subsidiary Awarded Slate of Government of Ohio-Funded Environmental Remediation Projects • Jan 15, 2025 7:33 AM

FEATURED Mawson Finland Begins 2025 Drill Program, Mobilizing Multiple Drill Rigs at Rajapalot • Jan 15, 2025 7:18 AM

VOCODIA HOLDINGS INC. (OTCMKTS: VHAI) and TRACCOM INC. (OTCMKTS: TRCC) have signed an MOU to form a Joint Venture that will Revolutionize Event Monitoring with Narrative AI • VHAI • Jan 15, 2025 2:53 PM

UAV Corp (OTC: UMAV) Engages Legal Counsel to Initiate Uplisting Process with Ultimate Goal of NASDAQ Listing • UMAV • Jan 15, 2025 8:30 AM

HealthLynked Welcomes Jeremy Daniel as Chief Financial Officer • HLYK • Jan 15, 2025 8:00 AM

GreetEat Corporation Announces Ticker Symbol Change to GEAT on OTC Markets • GEAT • Jan 14, 2025 9:40 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow